🇮🇹 Kymriah in Italy

Kymriah (TISAGENLECLEUCEL) regulatory status in Italy.

Marketing authorisation

AIFA

  • Local brand name: Kymriah
  • Status: approved

Kymriah in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in Italy

Frequently asked questions

Is Kymriah approved in Italy?

Yes. AIFA has authorised it.

Who is the marketing authorisation holder for Kymriah in Italy?

Novartis Pharmaceuticals Corporation is the originator. The local marketing authorisation holder may differ — check the official source linked above.